A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males

Trial Identifier: D6400C00001
Sponsor: AstraZeneca
NCTID:: NCT02484729
Start Date: July 2015
Primary Completion Date: November 2015
Condition: Healthy Volunteers; Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom